(Q35882779)

10 August 2017

1 reference

title

The rare coagulation disorders--review with guidelines for management from the United Kingdom Haemophilia Centre Doctors' Organisation (English)

1 reference

10 August 2017

0 references

1 reference

Bolton-Maggs PH

1

1 reference

10 August 2017

Perry DJ

2

1 reference

10 August 2017

Chalmers EA

3

1 reference

10 August 2017

Parapia LA

4

1 reference

10 August 2017

Wilde JT

5

1 reference

10 August 2017

Williams MD

6

1 reference

10 August 2017

Collins PW

7

1 reference

10 August 2017

Kitchen S

8

1 reference

10 August 2017

Dolan G

9

1 reference

10 August 2017

Mumford AD

10

1 reference

10 August 2017

publication date

1 September 2004

1 reference

10 August 2017

1 reference

10 August 2017

volume

10

1 reference

10 August 2017

issue

5

1 reference

10 August 2017

page(s)

593-628

1 reference

Effect of 3.2% vs 3.8% sodium citrate concentration on routine coagulation testing.

10 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2004.00944.X

Prolonged prothrombin time and activated partial thromboplastin time due to underfilled specimen tubes with 109 mmol/L (3.2%) citrate anticoagulant

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2004.00944.X

The investigation and management of neonatal haemostasis and thrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2004.00944.X

A method for the determination of activated factor VII using bovine and rabbit brain thromboplastins: demonstration of increased levels in disseminated intravascular coagulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2004.00944.X

Assessment of Actin FS and Actin FSL sensitivity to specific clotting factor deficiencies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2004.00944.X

Sensitivity of three activated partial thromboplastin time reagents to coagulation factor deficiencies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2004.00944.X

Laboratory performance of haemophilia centres in developing countries: 3 years' experience of the World Federation of Hemophilia External Quality Assessment Scheme

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2004.00944.X

Autosomal recessive deficiencies of coagulation factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2004.00944.X

Bleeding and thrombosis in 55 patients with inherited afibrinogenaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2004.00944.X

Spontaneous intracranial bleeding in two patients with congenital afibrinogenaemia and the role of replacement therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2004.00944.X

Prenatal and peripartum management of congenital afibrinogenaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2004.00944.X

21 January 2018

The dysfibrinogenaemias

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2004.00944.X

Prothrombin deficiency results in embryonic and neonatal lethality in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2004.00944.X

Rare coagulation deficiencies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2004.00944.X

Symptoms of inherited factor V deficiency in 35 Iranian patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2004.00944.X

Factor V inhibitor in neonatal intracranial hemorrhage secondary to severe congenital factor V deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2004.00944.X

Severe factor V deficiency and neonatal intracranial haemorrhage: a case report

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2004.00944.X

SD Plasma in TTP and coagulation factor deficiencies for which no concentrates are available

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2004.00944.X

Mutations in the ER-Golgi intermediate compartment protein ERGIC-53 cause combined deficiency of coagulation factors V and VIII

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2004.00944.X

The comparative role of consanguinity in infant and childhood mortality in Pakistan

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2004.00944.X

Combined factors V and VIII deficiency--the solution

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2004.00944.X

Mannose-dependent endoplasmic reticulum (ER)-Golgi intermediate compartment-53-mediated ER to Golgi trafficking of coagulation factors V and VIII.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2004.00944.X

Bleeding symptoms in 27 Iranian patients with the combined deficiency of factor V and factor VIII.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2004.00944.X

21 January 2018

Factor VII Deficiency

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2004.00944.X

Clinical manifestations in 28 Italian and Iranian patients with severe factor VII deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2004.00944.X

Pharmacokinetics and pharmacodynamics of recombinant factor VIIa

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2004.00944.X

Clinical study of recovery and half-life of vapor-heated factor VII concentrate

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2004.00944.X

Recombinant factor VIIa for patients with inhibitors to factor VIII or IX or factor VII deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2004.00944.X

Recombinant factor VIIa for the treatment of congenital factor VII deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2004.00944.X

Clinical efficacy and recovery levels of recombinant FVIIa (NovoSeven) in the treatment of intracranial haemorrhage in severe neonatal FVII deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2004.00944.X

Continuous infusion of recombinant activated factor VII during caesarean section delivery in a patient with congenital factor VII deficiency.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2004.00944.X

Congenital factor X deficiency: spectrum of bleeding symptoms in 32 Iranian patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2004.00944.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2004.00944.X

Prophylactic treatment of severe factor X deficiency with prothrombin complex concentrate

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2004.00944.X

Homozygosity mapping of a second gene locus for hereditary combined deficiency of vitamin K-dependent clotting factors to the centromeric region of chromosome 16.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2004.00944.X

Mutations in VKORC1 cause warfarin resistance and multiple coagulation factor deficiency type 2

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2004.00944.X

Combined deficiency of factors II, VII, IX, and X (Borgschulte-Grigsby deficiency) in pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2004.00944.X

Factor XI deficiency in French Basques is caused predominantly by an ancestral Cys38Arg mutation in the factor XI gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2004.00944.X

Assessment of menstrual blood loss and gynaecological problems in patients with inherited bleeding disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2004.00944.X

Quality of life during menstruation in patients with inherited bleeding disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2004.00944.X

Successful use of recombinant factor VIIa in a patient with inhibitor secondary to severe factor XI deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2004.00944.X

Delayed umbilical bleeding--a presenting feature for factor XIII deficiency: clinical features, genetics, and management.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2004.00944.X

21 January 2018

Factor XIII deficiency

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2004.00944.X

Determination of factor XIII activity by a new photometric assay in plasma and platelets of healthy blood donors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2004.00944.X

Factor XIII: inherited and acquired deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2004.00944.X

Bleeding risk and reproductive capacity among patients with factor XIII deficiency: a case presentation and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2004.00944.X

Coagulation Factor Deficiencies and Pregnancy Loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2004.00944.X

Ehlers-Danlos syndromes: revised nosology, Villefranche, 1997. Ehlers-Danlos National Foundation (USA) and Ehlers-Danlos Support Group (UK).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2004.00944.X

10.1111/J.1365-2516.2004.00944.X

21 January 2018

Identifiers

DOI

1 reference

10 August 2017

1 reference